Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Age-Related Macular Degeneration

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Tongren Hospital, Capital Medical University, Beijing, China
Contact: Study coordinator (Wenbin Wei, PhD) · tr_weiwenbin@163.com · 86 13701255115

Study leads

Wenbin Wei, PhD
Principal Investigator
Beijing Tongren Hospital Affiliated to Capital Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Geographic Atrophy · Age-Related Macular Degeneration

Abroad (travel likely)RecruitingPHASE1, PHASE2

Carmel, United States · Reno, United States

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Geographic Atrophy Secondary to Age-related Macular Degeneration

Abroad (travel likely)RecruitingPHASE2

Huntington Beach, United States · Sacramento, United States

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Geographic Atrophy · Macular Degeneration

Abroad (travel likely)RecruitingPHASE2

Tucson, United States · Fullerton, United States

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

Geographic Atrophy Secondary to Age-related Macular Degeneration

Abroad (travel likely)RecruitingPHASE2

Gilbert, United States · Mesa, United States